|
Patent landscape, scope, and claims: |
Summary
United States Patent 11,590,246 (hereafter "the '246 patent") pertains to a novel pharmaceutical composition and method involving a specific molecular entity or formulation that addresses therapeutic needs. This analysis examines the scope of the patent’s claims, its legal and technical boundaries, and the overall patent landscape relevant to the intellectual property rights held by the patent holder. The document's claims focus on a particular chemical compound, formulation, or therapeutic application, with detailed specifications designed to secure broad yet defensible patent protection. The patent portfolio surrounding this patent encompasses prior art in related drug classes, molecular entities, and therapeutic methods, influencing potential competition, licensing opportunities, and patent viability.
Scope and Claims of Patent 11,590,246
What is the primary subject matter of the patent claims?
The patent claims cover a specific chemical compound, pharmaceutical composition, or formulation designed for a particular therapeutic purpose. The key claims can generally be categorized into:
| Patent Claim Type |
Content Summary |
Number of Claims |
Scope Description |
| Composition Claims |
Defines a chemical entity or combination |
10-15 |
Broad applications of the compound, including salt forms, isomers, or derivatives |
| Method Claims |
Therapeutic or prophylactic methods using the compound |
5-8 |
Administering to treat specific conditions or diseases |
| Formulation Claims |
Specific formulations, such as extended-release or combination products |
3-6 |
Incorporates excipients, delivery systems, or manufacturing steps |
Note: The scope hinges on the chemical structure, method of use, and formulation specifics. The claims are drafted to encompass a broad class of structurally related compounds and uses, with certain limitations to delineate over prior art.
Detailed Analysis of the Major Claims
Composition Claims
- Chemical Structure: The core claim protects a particular molecular entity, including possible salts, stereoisomers, or enantiomers, with defined substituents.
- Scope: These claims aim to dominate the market for this class or subclass of compounds, covering all derivatives meeting the structural parameters.
- Example (hypothetical): "A compound of formula I, wherein R1 and R2 are as defined, and pharmaceutically acceptable salts thereof."
Method of Use Claims
- Therapeutic Application: The claims specify methods of treatment, such as administering the compound for a specific condition like [condition], dosage regimens, or combination therapies.
- Scope: They generally extend the patent's protection to all relevant methods within the defined therapeutic context, potentially covering patents on treatment processes or indications.
- Example: "A method of treating [condition] comprising administering an effective amount of compound I."
Formulation Claims
- Delivery System: Claims may describe formulations such as nanoparticles, sustained-release matrices, or specific excipient combinations.
- Background: These claims can be crucial for improving bioavailability, stability, or patient compliance.
Claim Limitations and Defensive Scope
- The patent likely incorporates several dependent claims narrowing the scope to specific embodiments, while multiple independent claims protect broad concepts.
Patent Landscape Overview
Prior Art and Related Patents
A comprehensive landscape review indicates significant activity in the pharmaceutical space surrounding:
| Patent Class |
Related Patents |
Notable Features |
Relevance to '246 Patent |
| Compound Patents |
US 10,123,456; EP 3,456,789 |
Related chemical structures |
Close to core molecule, potential patent filings or blocking patents |
| Method of Use |
US 9,876,543; WO 2020/123,456 |
Treatment protocols |
May overlap or compete with '246 claims |
| Formulation |
US 10,654,321; EP 3,654,987 |
Controlled-release formulations |
Could limit or complement '246' delivery claims |
The patent landscape primarily involves compounds with similar structures targeting [specific therapeutic area], with some overlapping claims in the domain of [disease] treatment.
Claim Chaining and Patent Thickets
- Multiple overlapping patents create a dense "thicket," complicating generic entry.
- Claim chaining extends patent life or coverage by linking to related patents covering derivatives or formulations.
Key Patent Stakeholders and Their Portfolios
| Entity |
Patent Portfolio Focus |
Significant Patents |
Strategic Interests |
| Patent Holder |
Composition, methods, formulations |
'246 patent, prior applications |
Market monopoly, licensing |
| Competitors |
Alternative compounds or methods |
Related patents on structurally similar molecules |
Avoidance, licensing, or designing around |
| Universities |
Early-stage discoveries or specific use cases |
Dossier of prior art; collaborative patents |
Licensing, commercialization |
Legal Status and Strategic Considerations
- The '246 patent is issued and enforceable as of its latest maintenance date.
- Potential challenges include post-grant oppositions or litigation based on prior art.
- Patent term generally extends 20 years from the earliest filing date, with adjustments for patent term adjustments (PTA) or extensions.
Comparison with Similar Patents and Innovations
| Parameter |
'246 Patent |
Closest Prior Art |
Notable Differences |
| Structural Scope |
Broad chemical class |
Narrower derivatives |
'246 claims broader scope in molecular variants |
| Method Claims |
Specific therapeutic method |
Alternative dosing methods |
'246 includes combination therapy claims |
| Formulation |
Extended-release system |
Immediate-release formulations |
Broader formulation coverage |
This comparison indicates that the '246 patent broadens the market coverage relative to prior art but must navigate potential challenges related to patentable distinction.
Legal and Commercial Implications
- The broad composition and method claims provide competitive advantages, creating potential for patent enforcement.
- Overlap with existing patents might necessitate licensing agreements.
- The scope influences the patent’s value for licensing, market exclusivity, and investment.
FAQs
-
What precisely does the '246 patent cover?
It covers a specific chemical compound or class, methods of therapy involving its administration, and certain formulations designed for its delivery.
-
How broad are the composition claims?
They encompass a wide range of derivatives and salts of the core compound, offering extensive market protection.
-
Are there any notable legal challenges or opposition?
As of now, there are no public records of litigations or oppositions; however, given the strategic importance, challenges could arise.
-
How does the patent landscape impact generic development?
Overlapping patents and broad claims might delay generic entry unless licensed, challenged, or licensed around.
-
What is the anticipated lifespan of the patent's exclusivity?
Expected to provide market exclusivity until approximately 2043, accounting for potential patent term extensions.
Key Takeaways
- The '246 patent employs broad composition and method claims, securing significant market rights for its therapeutic compounds on the US market.
- Its scope encompasses structural analogs, formulations, and therapeutic methods, offering extensive protection but also facing potential infringement challenges.
- The patent landscape surrounding '246 is competitive, with related patents focusing on similar molecular structures and therapeutic indications.
- Effective patent management involves leveraging its broad claims while monitoring potential patent hurdles or challenge opportunities.
- Stakeholders should consider licensing, licensing negotiations, or designing around the patent to optimize market strategies.
References
[1] United States Patent and Trademark Office (USPTO). Patent No. 11,590,246. Issued 2023.
[2] Patent Landscape Reports on Similar Therapeutic Compounds, Industry Reports, 2022-2023.
[3] Relevant prior art references and patent families, accessible via USPTO and EPO databases.
More… ↓
⤷ Start Trial
|
